Stocks / NASDAQ / Axovant Gene Therapies Ltd.

Axovant Gene Therapies Ltd.

Our Opinion

Axovant Gene Therapies Ltd. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for product testing.

“In summary, these experiments were determined to demonstrate the long-term safety of therapeutic doses of ProSavin as well as significant efficacy to improve measures of movement and reduce dyskinesias in animal models. These results supported the initiation of clinical trials for ProSavin.” (Page 7) Read the full document

Company Description

Company Website: